When patients were analyzed across the AD continuum, from preclinical AD to MCI-AD and fully developed AD dementia, CSF UCH-L1 levels increased progressively when compared with MCI and subjective cognitive decline (SCD), in the presence of negative CSF AD profiles. The gene discussed is UCHL1; the disease is dementia.